MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $760 | $760 | $760 |
| - Cash | $38 | $80 | $28 |
| + Debt | $7 | $6 | $6 |
| Enterprise Value | $728 | $686 | $738 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 |
| % Margin | – | – | – |
| EBITDA | -$77 | -$55 | -$29 |
| % Margin | – | – | – |
| Net Income | -$78 | -$56 | -$30 |
| % Margin | – | – | – |
| EPS Diluted | -1.87 | -1.34 | -0.72 |
| % Growth | -39.6% | -86.1% | – |
| Operating Cash Flow | -$79 | -$52 | -$27 |
| Capital Expenditures | -$1 | -$0 | -$1 |
| Free Cash Flow | -$80 | -$52 | -$27 |